mecobalamin
Small moleculeexperimental
Methylcobalamin (mecobalamin, MeCbl, or MeB12) is a cobalamin, a form of vitamin B12. It differs from cyanocobalamin in that the cyano group at the cobalt is replaced with a methyl group. Methylcobalamin features an octahedral cobalt(III) centre and can be obtained as bright red crystals. From the perspective of coordination chemistry, methylcobalamin is notable as a rare example of a compound that contains metal–alkyl bonds. Nickel–methyl intermediates have been proposed for the final step of methanogenesis. — Wikipedia
Clinical trial activity
24 trials · 24 clinical orgs · 0 marketing orgs
Phase 1
4
Phase 2
7
Phase 3
6
Phase 4
5
Earliest trial started Mar 1, 2003 (NCT00165711)
Timeline
Indications
Approved for
Studied for
- Amyotrophic Lateral Sclerosis · Phase 2/Phase 3
- Autistic Disorder · Phase 2/Phase 3
- Brain Injuries · Phase 2
- Cognitive Dysfunction · Phase 2
- Diabetes Mellitus · Phase 4
- Diabetes Mellitus, Type 2 · Phase 2/Phase 3
- Diabetic Retinopathy · Phase 2
- Facial Nerve Injuries · Early Phase 1
- Fibromyalgia · Phase 1/Phase 2
- Hand-Foot Syndrome · Phase 3
- Healthy Volunteers · Phase 1
- Hydroxocobalamin · Phase 4
- Liver Diseases · Phase 4
- Lung Diseases · Phase 2/Phase 3
- Nerve Degeneration · Phase 2
- Neurovascular Coupling · Phase 2
- Peripheral Nervous System Diseases · Phase 4
- Retinal Diseases · Phase 4
- Sepsis · Phase 4
- Vitamin B 12 Deficiency · Phase 2
Mechanism of action
- Methionine synthaseSupplementation
MTR supplementation
Chemistry & pharmacology
- Mol. weight
- 1344.4 g/mol
- Chirality
- Achiral Molecule
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- WikipediaMethylcobalamin ↗
- ChEMBLCHEMBL2448537 ↗
- ChEMBLCHEMBL2359370 ↗
Also known as
- asimil b-12
- b-max
- ch3-b12
- cobinamide, co-methyl deriv., hydroxide, dihydrogen phosphate (ester), inner salt, 3'-ester with 5,6-dimethyl-1-alpha-d-ribofuranosyl-1h-benzimidazole
- co-methylcobalamin
- mecbl
- mecbl
- mecobalamin
- mecobalamin
- mecobalamin
- mecobalamin
- mecobalamin
- mecobalamin
- mecobalamin
- mecobalamin, (13beta)-isomer
- mecobalamin, 3h-labeled
- mecobalamin, 57co-labeled
- mecobalamin, co-methyl-13c-labeled
- mecobalamin, co-methyl-14c-labeled
- mecobalamin monohydrate
- methycobal
- methylcobalamin
- methylcobalamin
- methylcobalamin
- methylcobalamin
- methylcobalamin
- methylcobalamine
- methyl cobalamine
- methylcobaz
- methyl(iii)cobalamin
- methyl(iii)cobalamin
- methyl vitamin b12
- methylvitamin b12
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06813274 | Phase 2 | Jan 1, 2026 | Chengdu University of Traditional Chinese Medicines |
| NCT07274696 | Phase 3 | Dec 1, 2025 | Sanya People's Hospital, Sichuan University |
| NCT07281872 | Phase 1 | Oct 29, 2025 | WanBangDe Pharmaceutical Group Co.,Ltd. |
| NCT07158099 | Phase 1 | Sep 15, 2025 | WanBangDe Pharmaceutical Group Co.,Ltd. |
| NCT07133438 | Phase 4 | Sep 1, 2025 | Chongqing Medical University |
| NCT06220929 | Phase 4 | Jan 15, 2024 | Sichuan University |
| NCT05623384 | N/A | Nov 14, 2022 | Yangzhou University |
| NCT05184049 | Phase 4 | Jan 31, 2022 | Central South University |
| NCT05165069 | Phase 3 | Jan 1, 2022 | Sun Yat-Sen University |
| NCT04800666 | N/A | Mar 1, 2021 | Yangzhou University |
| NCT03968042 | Phase 2 | Jun 30, 2019 | Sun Yat-Sen University |
| NCT03983200 | N/A | Jun 15, 2019 | Nanjing Medical University |
| NCT05008042 | Phase 1/Phase 2 (Phase 2) | Feb 6, 2019 | Karolinska Institute, Kronoberg County Council, Landstinget i Kalmar Län, Linnaeus University, Region Östergötland |
| NCT02923388 | Phase 2 | Oct 1, 2016 | Bangladesh Medical University |
| NCT02853942 | Early Phase 1 (Phase 1) | Oct 1, 2016 | Jiao Tong University |
| NCT03167918 | Phase 2/Phase 3 (Phase 3) | Jul 21, 2014 | Liaoning Hospital of Traditional Chinese Medicine |
| NCT02540642 | N/A | Oct 1, 2010 | SMT KASHIBAI NAVALE MEDICAL COLLEGE |
| NCT01192113 | Phase 4 | Apr 1, 2010 | Eisai, People's Liberation Army of China |
| NCT00699478 | Phase 2 | Apr 1, 2008 | Yonsei University |
| NCT00445172 | Phase 2/Phase 3 (Phase 3) | Feb 1, 2008 | Eisai |
Showing 20 of 24 trials
Page 1 / 2
Organizations
Research & Development (24)
24 organizations
Page 1 / 2